User profiles for M. Gore

Michael Gore

Professor, Cornell University
Verified email at cornell.edu
Cited by 15827

Status and prospects of association mapping in plants

C Zhu, M Gore, ES Buckler, J Yu - The plant genome, 2008 - Wiley Online Library
There is tremendous interest in using association mapping to identify genes responsible for
quantitative variation of complex traits with agricultural and evolutionary importance. Recent …

Field-based phenomics for plant genetics research

JW White, P Andrade-Sanchez, MA Gore… - Field Crops …, 2012 - Elsevier
A major challenge for crop research in the 21st century is how to predict crop performance
as a function of genetic architecture. Advances in “next generation” DNA sequencing have …

International consensus statement on allergy and rhinology: Allergic rhinitis–2023

…, M Platt, M Ramanathan Jr, M Raymond… - International forum of …, 2023 - Wiley Online Library
Background In the 5 years that have passed since the publication of the 2018 International
Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (ICAR‐Allergic Rhinitis …

[HTML][HTML] Sorafenib in advanced clear-cell renal-cell carcinoma

…, M Gore, S Freeman, B Schwartz, M Shan… - … England Journal of …, 2007 - Mass Medical Soc
Background We conducted a phase 3, randomized, double-blind, placebo-controlled trial of
sorafenib, a multikinase inhibitor of tumor-cell proliferation and angiogenesis, in patients …

[HTML][HTML] Intratumor heterogeneity and branched evolution revealed by multiregion sequencing

…, G Clark, L Pickering, G Stamp, M Gore… - New England journal …, 2012 - Mass Medical Soc
Background Intratumor heterogeneity may foster tumor evolution and adaptation and hinder
personalized-medicine strategies that depend on results from single tumor-biopsy samples. …

Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma

…, G Fierlbeck, W Tilgen, S Seiter, M Gore… - Journal of Clinical …, 2000 - ascopubs.org
… receive either oral temozolomide at a starting dosage of 200 mg/m 2 /d for 5 days every 28
days or intravenous (IV) DTIC at a starting dosage of 250 mg/m 2 /d for 5 days every 21 days. …

Carboplatin dosage: prospective evaluation of a simple formula based on renal function.

…, FE Boxall, ZH Siddik, IR Judson, ME Gore… - Journal of Clinical …, 1989 - ascopubs.org
A dosage formula has been derived from a retrospective analysis of carboplatin pharmacokinetics
in 18 patients with pretreatment glomerular filtration rates (GFR) in the range of 33 to …

Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing

…, S Gulati, PA Bates, G Stamp, L Pickering, M Gore… - Nature …, 2014 - nature.com
… In conclusion, M-seq identified heterogeneous genomic landscapes and branched evolution
for each of ten sporadic VHL-deficient ccRCCs with spatially separated subclones, creating …

Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial

…, TE Hutson, MD Michaelson, VA Gorbunova, ME Gore… - The Lancet, 2011 - thelancet.com
Background The treatment of advanced renal cell carcinoma has been revolutionised by
targeted therapy with drugs that block angiogenesis. So far, no phase 3 randomised trials …

GAPIT: genome association and prediction integrated tool

…, Q Wang, J Peiffer, M Li, PJ Bradbury, MA Gore… - …, 2012 - academic.oup.com
Software programs that conduct genome-wide association studies and genomic prediction
and selection need to use methodologies that maximize statistical power, provide high …